Form 4 for ULTA Ulta Beauty
Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0000897069-23-000231 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-03 | ULTA | Ryan Anita Jane | CHRO | S - Sale+OE | $544.69 | -1,255 | 2,491 | -34% | -$683.6K |
| DM | 2023-04-04 | 2023-04-03 | ULTA | Ryan Anita Jane | CHRO | M - OptEx | $241.21 | +1,255 | 3,091 | +68% | +$302.7K |
| D | 2023-04-04 | 2023-03-31 | ULTA | Ryan Anita Jane | CHRO | A - Grant | $0.00 | +258 | 2,491 | +12% | $0 |
| D | 2023-04-04 | 2023-03-31 | ULTA | Ryan Anita Jane | CHRO | A - Grant | $0.00 | +1,051 | 1,051 | New | $0 |
| DM | 2023-04-04 | 2023-04-03 | ULTA | Ryan Anita Jane | CHRO | M - OptEx | $0.00 | -1,255 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | S | D | 1,255 | $544.69 | 2,491 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The prices actually received ranged from $544.6625 to $544.7100 The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price. |
| 2 | Common | Common Stock | 2023-04-03 | M | A | 655 | $204.27 | 3,746 | D | — | — | |
| 3 | Common | Common Stock | 2023-04-03 | M | A | 600 | $281.53 | 3,091 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-31 | A | A | 258 | $0.00 | 2,491 | D | — | — | (F1) Represents grant of 258 shares of restricted stock, vesting 100% on March 15, 2026. |
| 5 | Derivative | Stock Option (right to buy) | 2023-03-31 | A | A | 1,051 | $0.00 | 1,051 | D | $545.67 · — to 2033-03-31 | 1,051 Common Stock | (F3) The options, representing an initial right to purchase a total of 1,051 shares, vesting in 25% annual increments beginning March 15, 2024 and each anniversary thereafter through March 15, 2027. |
| 6 | Derivative | Stock Option (right to buy) | 2023-04-03 | M | D | 655 | $0.00 | 0 | D | $204.27 · — to 2028-03-29 | 655 Common Stock | (F5) The options, representing an initial right to purchase a total of 873 shares, vesting in 25% annual increments beginning March 15, 2019 and each anniversary thereafter through March 15, 2022. |
| 7 | Derivative | Stock Option (right to buy) | 2023-04-03 | M | D | 600 | $0.00 | 0 | D | $281.53 · — to 2027-03-24 | 600 Common Stock | (F4) The options, representing an initial right to purchase a total of 600 shares, vesting in 25% annual increments beginning March 15, 2018 and each anniversary thereafter through March 15, 2021. |